REVA Medical Inc (RVA) - Product Pipeline Analysis, 2017 Update

Summary

REVA Medical Inc (REVA) is a medical device company that develops minimally invasive medical devices. The companys product includes bioresorbable polymers. Its bioresorbable polymers can be applied to a variety of medical applications. REVAs fantom sirolimus-eluting bioresorbable scaffold is designed to provide acute benefits as permanent drug-eluting metal stents. It also develops proprietary polymers for scaffold performance. The companys polymer also serves as the drug-delivery coating on fantom. It operates in Australia, Brazil and New Zealand, among others. REVA is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company REVA Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
REVA Medical Inc Company Overview 4
REVA Medical Inc Company Snapshot 4
REVA Medical Inc Pipeline Products and Ongoing Clinical Trials Overview 4
REVA Medical Inc Pipeline Analysis Overview 7
REVA Medical Inc - Key Facts 7
REVA Medical Inc - Major Products and Services 8
REVA Medical Inc Pipeline Products by Development Stage 9
REVA Medical Inc Ongoing Clinical Trials by Trial Status 11
REVA Medical Inc Pipeline Products Overview 13
Fantom Encore 13
Fantom Encore Product Overview 13
Fantom Encore - Broader Matrix 14
Fantom Encore - Broader Matrix Product Overview 14
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold 15
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold Product Overview 15
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold Clinical Trial 16
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Thinner Version 17
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Thinner Version Product Overview 17
Fantom Sirolimus-Eluting Bioresorbable Peripheral Scaffold 18
Fantom Sirolimus-Eluting Bioresorbable Peripheral Scaffold Product Overview 18
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold 19
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold Product Overview 19
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold 20
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold Product Overview 20
REVA Medical Inc - Key Competitors 21
REVA Medical Inc - Key Employees 22
REVA Medical Inc - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
REVA Medical Inc, Recent Developments 24
Nov 07, 2017: REVA Medical Reports Third Quarter 2017 Financial Results 24
Oct 31, 2017: New Fantom Data Demonstrates Safety at 2 Years 25
Oct 31, 2017: New Fantom Data Demonstrates Safety at 2 Years 26
Oct 23, 2017: REVA to Present Fantom 24-Month Data at TCT 2017 27
Oct 16, 2017: REVA Announces Commercial Expansion and the First Implant of the Fantom Bioresorbable Scaffold in Switzerland 27
Oct 16, 2017: Fantom Bioresorbable Scaffold in Switzerland 28
Sep 20, 2017: Reva Announces Ray Larkin Jr. as Chairman ofthe Board of Directors 28
Sep 01, 2017: REVA Appoints Brandi Roberts as Chief Financial Officer and Company Secretary 28
Aug 10, 2017: REVA Medical: Half-Yearly Report 28
Aug 04, 2017: Boston Scientifics Distribution Option Lapses 30
Appendix 31
Methodology 31
About GlobalData 33
Contact Us 33
Disclaimer 34

List Of Tables


REVA Medical Inc Pipeline Products and Ongoing Clinical Trials Overview 4
REVA Medical Inc Pipeline Products by Equipment Type 5
REVA Medical Inc Pipeline Products by Indication 6
REVA Medical Inc Ongoing Clinical Trials by Trial Status 6
REVA Medical Inc, Key Facts 7
REVA Medical Inc, Major Products and Services 8
REVA Medical Inc Number of Pipeline Products by Development Stage 9
REVA Medical Inc Pipeline Products Summary by Development Stage 10
REVA Medical Inc Ongoing Clinical Trials by Trial Status 11
REVA Medical Inc Ongoing Clinical Trials Summary 12
Fantom Encore - Product Status 13
Fantom Encore - Product Description 13
Fantom Encore - Broader Matrix - Product Status 14
Fantom Encore - Broader Matrix - Product Description 14
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Status 15
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Description 15
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Expanded FANTOM II Clinical Study 16
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Pilot Study of the REVA Sirolimus-Eluting Bioresorbable Coronary Scaffold 16
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Safety & Performance Study of the FANTOM Sirolimus-eluting Bioresorbable Coronary Scaffold 16
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Thinner Version - Product Status 17
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Thinner Version - Product Description 17
Fantom Sirolimus-Eluting Bioresorbable Peripheral Scaffold - Product Status 18
Fantom Sirolimus-Eluting Bioresorbable Peripheral Scaffold - Product Description 18
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Status 19
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Description 19
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Product Status 20
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Product Description 20
REVA Medical Inc, Key Employees 22
REVA Medical Inc, Subsidiaries 23
Glossary 32

List Of Figures


REVA Medical Inc Pipeline Products by Equipment Type 5
REVA Medical Inc Pipeline Products by Development Stage 9
REVA Medical Inc Ongoing Clinical Trials by Trial Status 11

Global Myocardial Revascularization, Repair, and Regeneration Products and Therapies Market Research Report 2021-2025

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Myocardial Revascularization, Repair, and Regeneration Products and Therapies

USD 3200 View Report

Global Myocardial Revascularization, Repair, and Regeneration Products and Therapies Market Research Report 2019-2023

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Myocardial Revascularization, Repair, and Regeneration Products and Therapies

USD 2850 View Report

Profound Medical Inc - Product Pipeline Analysis, 2021 Update

Profound Medical Inc (Profound Medical) is a medical device company that develops and markets solutions to deliver precise ablation of prostate. Its proprietary technology, TULSA-PRO, by combining real-time magnetic resonance

USD 750 View Report

Avita Medical Inc (RCEL) - Financial and Strategic SWOT Analysis Review

Avita Medical Inc (RCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available